4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline,
BMS-345541,
BMS345541,
445430-58-0,
BMS-345541,
BMS345541,
BMS-345541 free base,
BMS-345541 (free base),
UNII-26SU0NEF5F,
IKK Inhibitor III,
BMS-345541(free base),
IKK Inhibitor III, BMS-345541,
N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine,
26SU0NEF5F,
C14H17N5,
4-(2′-Aminoethyl)amino-1,8-dimethylimidazo[1,2-a]quinoxaline,
Kinome_3215,
SCHEMBL118886,
CHEMBL249697,
GTPL5669,
BDBM25919,
CHEBI:91340,
CTK8E9618,
KS-00001CRN,
DTXSID60196216,
PSPFQEBFYXJZEV-UHFFFAOYSA-N,
4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline,
HMS2043P05,
HMS3653F06,
BCP06508,
EX-A2033,
ZINC1554390,
1,2-Ethanediamine, N-(1,8-dimethylimidazo(1,2-a)quinoxalin-4-yl)-,
1,2-Ethanediamine, N1-(1,8-dimethylimidazo(1,2-a)quinoxalin-4-yl)-,
2277AH,
s8044,
CS-1238,
NCGC00165761-01,
NCGC00165761-02,
BC600377,
DA-42424,
HY-10519,
RT-013303,
B4655,
SW219432-1,
A12559,
W-5711,
CU-00000000044-1,
BRD-K13566078-001-01-5,
4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a) quinoxaline,
N'-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine,
N-(2-aminoethyl)-1,8-dimethylimidazo[1,2-a]quinoxalin-4-amine,
N1-(1,8-Dimethylimidazo[1,2-a]quinoxalin-4-yl)-1,2-ethanediamine,
1,2-Ethanediamine,N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)-,
N-(2-aminoethyl)-3,12-dimethyl-2,5,8-triazatricyclo[7.4.0.0^{2,6}]trideca-1(13),3,5,7,9,11-hexaen-7-amine,
D00YTQ,
CHEMBL471496,
BMS 345541,
CID9813758,
CID 9813758,
C471109,
547757-23-3,